Related Experiment Video
Updated: Feb 15, 2026

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood
Published on: September 14, 2017
Infection Complications in Pediatric Patients With Inborn Errors of Immunity After Umbilical Cord Blood
Zhongling Wei1,2, Ping Wang1, Wenjin Jiang1
1Department of Hematology/Oncology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China.
Insights
Infections are common in children with inborn errors of immunity (IEIs) after umbilical cord blood transplantation (UCBT). Early-stage infections and bloodstream infections (BSIs) significantly worsen patient outcomes, highlighting the need for targeted surveillance.
Area of Science:
- Pediatric Hematology/Oncology
- Immunology
- Infectious Diseases
Background:
- Infection is a frequent complication after umbilical cord blood transplantation (UCBT).
- Data on infection profiles in pediatric patients with inborn errors of immunity (IEIs) in China are limited.
- This study characterizes infection patterns and their prognostic impact in IEIs children undergoing UCBT.
Purpose of the Study:
- To investigate infection prevalence and risk factors in pediatric IEIs patients post-UCBT.
- To determine the prognostic implications of different infection types and stages on patient survival.
- To inform risk-stratified surveillance and preemptive strategies for high-risk subgroups.
Main Methods:
- Retrospective analysis of 165 pediatric IEIs patients undergoing UCBT (January 2015 - June 2020).
- Categorization of post-transplantation period into early (≤30 days) and middle (31-100 days) stages.
- Statistical analysis to identify predictors of infection and their association with outcomes.
Main Results:
- 69.7% of patients experienced infections within 100 days post-UCBT.
- Engraftment failure, low pre-transplant IgM, and specific graft-versus-host disease (GVHD) prophylaxis regimens were linked to increased infection risk.
- Early-stage infections and bloodstream infections (BSIs) were associated with significantly poorer survival.
- Bacterial infections, particularly carbapenem-resistant strains, and BSIs correlated with adverse prognosis.
Conclusions:
- Infections are highly prevalent in pediatric IEIs patients following UCBT.
- Early-stage infections and BSIs are critical indicators of poor prognosis.
- Findings support the implementation of risk-stratified surveillance and preemptive interventions for vulnerable patient groups.
Background:
Infection is a common complication following umbilical cord blood transplantation (UCBT), yet comprehensive data on pediatric patients with inborn errors of immunity (IEIs) in China are scarce. This study aimed to characterize infection profiles and their prognostic implications in this population.
Methods:
We retrospectively analyzed 165 IEIs patients undergoing UCBT between January 2015 and June 2020. The post-transplantation period was divided into early (≤ 30 days) and middle (31-100 days) stages.
Results:
Within 100 days, 115 patients (69.7%) experienced 217 infection episodes. Engraftment failure was an independent predictor of infection risk within 100 days (OR = 2.97, p = 0.04). Low pre-transplantation IgM levels and graft-versus-host disease (GVHD) prophylaxis with calcineurin inhibitors (CNIs) plus mycophenolate mofetil (MMF) increased early-stage infection risks (p < 0.05). Infections at the middle stage were correlated with Grade II-IV acute GVHD (p = 0.03). Bloodstream infections (BSIs) were linked to CNIs combined with MMF and lower total nucleated cell counts in cord blood (p < 0.05). Early-stage infected group exhibited significantly poorer survival versus uninfected and middle-stage groups (p < 0.001). Patients without bacterial infections had higher survival rates than those with carbapenem-resistant or non-resistant infections (p < 0.05). BSIs were associated with poor prognosis (p < 0.05), while cytomegalovirus infection showed no significant survival impact (p = 0.05).
Conclusions:
Infections are highly prevalent in IEIs children post-UCBT, with early-stage events and BSI portending poorer outcomes. These findings advocate for risk-stratified surveillance and preemptive strategies in high-risk subgroups.
Related Concept Videos
Inborn Errors of Metabolism
Patient-centered Care
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

